we have applied a sensitive and discriminating electrophoretic technique that distinguishes between fibrinogen , fibrin polymers , fibrinogen degradation products ( fdp ) , and cross-linked fibrin degradation products ( xldp ) to evaluate urinary fibrinogen antigen in control subjects and in patients with a variety of renal diseases and after renal allograft transplantation .
C0015982
fibrin
C0163275
fibrin degradation products